Dongjun Lv
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dongjun Lv has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Chun-Feng Liu
Department of Neurology The Second Affiliated Hospital of Soochow University Suzhou Jiangsu China
1 shared publication Fen Wang
Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou 215123, China
1 shared publicationJing Chen
Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
1 shared publication- Li-Fang Hu
Department of Neurology and Clinical Research Center of Neurological Disease The Second Affiliated Hospital of Soochow University Suzhou Jiangsu China
1 shared publication Siyue Li
Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
1 shared publicationWenwen Liu
Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou 215123, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 4854732
Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1‐BMAL1 Pathway in 6‐OHDA‐Induced Models of Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease and is known to involve circadian dysfunction and oxidative stress. Although antioxidative defense is regulated by the molecular circadian clock, few studies have examined their function in PD and their regulation by silent information regulator 1 (SIRT1). We hypothesize that reduced antioxidative activity in models of PD results from dysfunction of the molecular circadian clock via the SIRT1 pathway. We treated rats and SH‐SY5Y cells with 6‐hydroxydopamine (6‐OHDA) and measured the expression of core circadian clock and associated nuclear receptor genes using real‐time quantitative PCR as well as levels of SIRT1, brain and muscle Arnt‐like protein 1 (BMAL1), and acetylated BMAL1 using Western blotting. We found that 6‐OHDA treatment altered the expression patterns of clock and antioxidative molecules in vivo and in vitro. We also detected an increased ratio of acetylated BMAL1:BMAL1 and a decreased level of SIRT1. Furthermore, resveratrol, an activator of SIRT1, decreased the acetylation of BMAL1 and inhibited its binding with CRY1, thereby reversing the impaired antioxidative activity induced by 6‐OHDA. These results suggest that a dysfunctional circadian clock contributes to an abnormal antioxidative response in PD via a SIRT1‐dependent BMAL1 pathway.
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 4854732
Open AccessDisruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1‐BMAL1 Pathway in 6‐OHDA‐Induced Models of Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease and is known to involve circadian dysfunction and oxidative stress. Although antioxidative defense is regulated by the molecular circadian clock, few studies have examined their function in PD and their regulation by silent information regulator 1 (SIRT1). We hypothesize that reduced antioxidative activity in models of PD results from dysfunction of the molecular circadian clock via the SIRT1 pathway. We treated rats and SH‐SY5Y cells with 6‐hydroxydopamine (6‐OHDA) and measured the expression of core circadian clock and associated nuclear receptor genes using real‐time quantitative PCR as well as levels of SIRT1, brain and muscle Arnt‐like protein 1 (BMAL1), and acetylated BMAL1 using Western blotting. We found that 6‐OHDA treatment altered the expression patterns of clock and antioxidative molecules in vivo and in vitro. We also detected an increased ratio of acetylated BMAL1:BMAL1 and a decreased level of SIRT1. Furthermore, resveratrol, an activator of SIRT1, decreased the acetylation of BMAL1 and inhibited its binding with CRY1, thereby reversing the impaired antioxidative activity induced by 6‐OHDA. These results suggest that a dysfunctional circadian clock contributes to an abnormal antioxidative response in PD via a SIRT1‐dependent BMAL1 pathway.